Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Lung Cancer (Amsterdam, Netherlands)|February 24, 2020
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangementGiuseppe Bronte, Angelo Delmonte, Marco Angelo Burgio, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 22, 2016
A headlight on liquid biopsies: a challenging tool for breast cancer managementDaniela Massihnia, Alessandro Perez, Viviana Bazan, et al.
Expert Opinion on Drug Safety|December 16, 2014
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapyGiuseppe Bronte, Enrico Bronte, Giuseppina Novo, et al.
Current Drug Targets|December 17, 2014
The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?Francesco Passiglia, Nele Van Der Steen, Luis Raez, et al.
Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.
Cancers|May 28, 2022
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer PatientsPaola Ulivi, Milena Urbini, Elisabetta Petracci, et al.
Frontiers in Oncology|May 21, 2021
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung CancerGiuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, et al.
Cancers|September 23, 2022
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung CancerValentina Danesi, Ilaria Massa, Flavia Foca, et al.
Translational Oncology|June 12, 2018
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, et al.
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Pageof 11